Primary Site >> Esophagus Cancer
Gene >> KDR
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. PMID: 12553021 |
Ref: Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. PMID: 17200341 |
Ref: Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway. PMID: 18452159 Ref: Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer. PMID: 18813825 |
Ref: Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways. PMID: 20039326 |
Ref: VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression. PMID: 21482472 |
Ref: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients. PMID: 24708624 Ref: New directions in perioperative management of locally advanced esophagogastric cancer. PMID: 24857100 |
Ref: Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy. PMID: 25595897 Ref: Characterization of the expression and clinical features of epidermal growth factor receptor and vascular endothelial growth factor receptor-2 in esophageal carcinoma. PMID: 26788193 |
Ref: Gastric Carcinoma at the Era of Targeted Therapies. PMID: 25944013 Ref: Targeted therapy in esophageal cancer. PMID: 26895097 Ref: New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints. PMID: 27370606 Ref: Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. PMID: 28078044 |
Ref: Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. PMID: 26986978 |
Ref: Contrast-enhanced computed tomography combined with Chitosan-Fe3O4 nanoparticles targeting fibroblast growth factor receptor and vascular endothelial growth factor receptor in the screening of early esophageal cancer. PMID: 29805549 Ref: Survivin is critically involved in VEGFR2 signaling-mediated esophageal cancer cell survival. PMID: 30086460 Ref: MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer. PMID: 30245290 |